BWI CTU: Baltimore-Washington-India Clinical Trials Unit

Post Date: 
Clinical Sites: 

Comprising clinical trial sites at Johns Hopkins Medicine in Baltimore, Whitman Walker Health in Washington, DC, and the BJGMC-CCGHE collaboration in Pune, India, the Baltimore-Washington-India Clinical Trials Unit (BWI-CTU) is one of only 25 international HIV/TB clinical trial sites funded by the US NIH, and the only NIH-funded site to conduct HIV/TB network studies in children and pregnant women in India. The BWI-CTU research group participates in clinical trials that address and contribute to two research priority areas:  1) Prevention of mother-to-child HIV transmission and 2) Optimization of clinical management of HIV/AIDS, including optimal treatment regimens for adults and children with HIV as well as prevention and treatment of TB, cryptococcal meningitis, HPV co-infections and other HIV-related conditions. In collaboration with two NIAID HIV/AIDS Clinical Trials networks (the AIDS Clinical Trials Group [ACTG] and the International Maternal Pediatric Adolescent AIDS Clinical Trials [IMPAACT] group), the BJGMC-CCGHE research collaborative has been part of more than a dozen clinical trials.

  • BJGMC, Pune, India
  • Whitman Walker Health, Washington, DC
  • Johns Hopkins Medicine, Baltimore, MD